Ajooni Biotech (NSE:AJOONI) Cyclically Adjusted Revenue per Share: ₹20.94 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AJOONI Ajooni Biotech Ltd NSE:AJOONI
62 GF Score
Price ₹3.47
GF Value ₹6.16
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Ajooni Biotech Cyclically Adjusted Revenue per Share?

Ajooni Biotech NSE:AJOONI -0.86% 62 Cyclically Adjusted Revenue per Share is ₹20.94 as of Mar. 2026. GuruFocus rates NSE:AJOONI with a GF Score™ of 62/100 and a GF Value™ of ₹6.16 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ajooni Biotech's adjusted revenue per share data for the fiscal year that ended in Mar. 2026 was ₹10.588. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹20.94 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ajooni Biotech's average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ajooni Biotech was 37.70% per year. The lowest was 7.00% per year. And the median was 22.35% per year.

As of today (2026-09-12), Ajooni Biotech's current stock price is ₹ 3.47. Ajooni Biotech's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar. 2026 was ₹20.94. Ajooni Biotech's Cyclically Adjusted PS Ratio of today is 0.17.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ajooni Biotech was 1.41. The lowest was 0.18. And the median was 0.26.


Ajooni Biotech  (NSE:AJOONI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ajooni Biotech's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.47/20.94
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ajooni Biotech was 1.41. The lowest was 0.18. And the median was 0.26.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ajooni Biotech Cyclically Adjusted Revenue per Share Related Terms


Ajooni Biotech Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ajooni Biotech's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajooni Biotech Cyclically Adjusted Revenue per Share Chart

Ajooni Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.49 17.11 18.62 19.55 20.94

Ajooni Biotech Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 19.55 20.94

NSE:AJOONI vs KHC, GIS: Cyclically Adjusted Revenue per Share Comparison

For the Packaged Foods subindustry, Ajooni Biotech's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajooni Biotech Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Ajooni Biotech's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ajooni Biotech's Cyclically Adjusted PS Ratio falls into.


NSE:AJOONI
62GF Score
Ajooni Biotech Ltd NSE:AJOONI
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajooni Biotech Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ajooni Biotech's adjusted Revenue per Share data for the fiscal year that ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=10.588/164.2724*164.2724
=10.588

Current CPI (Mar. 2026) = 164.2724.

Ajooni Biotech Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201703 6.820 105.196 10.650
201803 10.128 109.786 15.154
201903 9.061 118.202 12.593
202003 7.406 124.705 9.756
202103 7.932 131.771 9.888
202203 11.390 138.822 13.478
202303 99.836 146.865 111.670
202403 8.062 153.035 8.654
202503 6.659 157.552 6.943
202603 10.588 164.272 10.588

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹20.94 mean?
Ajooni Biotech (NSE:AJOONI) has a Cyclically Adjusted Revenue per Share of ₹20.94 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ajooni Biotech and its competitors.
Is Ajooni Biotech's Cyclically Adjusted Revenue per Share too high?
Ajooni Biotech's current Cyclically Adjusted Revenue per Share is ₹20.94. Overall, Ajooni Biotech has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ajooni Biotech's Cyclically Adjusted Revenue per Share compare to KHC and GIS?
Ajooni Biotech's Cyclically Adjusted Revenue per Share of ₹20.94 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Revenue per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ajooni Biotech and its competitors. Ajooni Biotech's current Cyclically Adjusted Revenue per Share is ₹20.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajooni Biotech stock overvalued right now?
Based on GuruFocus' analysis, Ajooni Biotech (NSE:AJOONI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹6.16, compared to a current price of ₹3.47 — trading 43.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹20.94. Ajooni Biotech's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ajooni Biotech (NSE:AJOONI), the current Cyclically Adjusted Revenue per Share is ₹20.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ajooni Biotech (NSE:AJOONI) Overvalued in 2026?

Based on GuruFocus' analysis, Ajooni Biotech stock appears to be undervalued. The current stock price of ₹3.47 is trading 43.7% below its estimated GF Value™ of ₹6.16. GuruFocus considers Ajooni Biotech to be Possible Value Trap.

Key valuation signals for NSE:AJOONI:

  • Cyclically Adjusted Revenue per Share: ₹20.94
  • GF Value™: ₹6.16 vs. price of ₹3.47 (43.7% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the NSE:AJOONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ajooni Biotech Business Description

Address House No. 1769, Phase 3B2, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
62GF Score

Get the complete analysis for NSE:AJOONI

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.47
Price
₹6.16
GF Value